Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-12

Clinical Trial Update: C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia

View source ↗

Summary

A clinical trial update concerning C-X-C chemokine receptor 4 in chronic lymphocytic leukemia, sponsored by Assiut University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Chronic Lymphocytic Leukemia | Status: UNKNOWN